Details
New companies 124 · Follow-on 1
Stages: Series A 39, Seed 36, Series C+ 18, Series B 17, Undisclosed 9, Pre-seed 6
Nous Research $90M Series BSanté $15M Series AVitalize $31M Series ARanked by rounds participated in, from announcements in Jan 1, 2026 – Oct 9, 2026. Lead counts include only confirmed lead roles.
New companies 124 · Follow-on 1
Stages: Series A 39, Seed 36, Series C+ 18, Series B 17, Undisclosed 9, Pre-seed 6
Nous Research $90M Series BSanté $15M Series AVitalize $31M Series ANew companies 87 · Follow-on 7
Stages: Series C+ 32, Series A 22, Series B 15, Seed 11, Undisclosed 9, Pre-seed 3, Growth 2
TypeSafe AI $870M Series AArena $200M Series BVesta $30M Series BNew companies 62 · Follow-on 2
Stages: Series C+ 16, Seed 15, Series A 15, Series B 11, Undisclosed 6, Growth 1, Pre-seed 1
Minerva Humanoids Undisclosed Pre-SeedMelius $20M Series AMelius $5M SeedNew companies 54 · Follow-on 1
Stages: Series A 19, Seed 13, Series B 12, Series C+ 5, Undisclosed 4, Growth 1, Pre-seed 1
Savvy Wealth $100M Series CMona $3.5M Oversubscribed roundAmerican Supercritical $8M Pre-seedNew companies 53 · Follow-on 1
Stages: Series B 14, Series C+ 14, Series A 11, Seed 9, Undisclosed 6
Arena $200M Series BVinci $250M Series BConway Research Undisclosed First financingNew companies 51 · Follow-on 2
Stages: Series C+ 20, Series A 12, Series B 9, Undisclosed 7, Seed 4, Pre-seed 1
Arena $200M Series BEnveda $311M Series EAnde Undisclosed Series ANew companies 46 · Follow-on 5
Stages: Series C+ 26, Series B 9, Undisclosed 6, Series A 4, Seed 3, Growth 2, Pre-seed 1
TypeSafe AI $870M Series AMecka $60M Series BHealthleap $8M SeedNew companies 35 · Follow-on 2
Stages: Series B 12, Series A 10, Series C+ 8, Undisclosed 3, Growth 2, Pre-seed 1, Seed 1
Armadin $255.5M Series BBigHat Biosciences $75M Series CPrime Minute $15M Pre-SeedNew companies 30 · Follow-on 7
Stages: Series A 10, Series B 9, Series C+ 7, Seed 6, Undisclosed 5
Armadin $255.5M Series BAndo $20M Combined pre-seed and seedEma $77M Series BNew companies 35 · Follow-on 2
Stages: Series A 11, Series C+ 10, Series B 5, Seed 4, Undisclosed 4, Pre-seed 2, Growth 1
Miter $40M Series BEliseAI $350M Growth financingStarSling Undisclosed Pre-SeedNew companies 35 · Follow-on 1
Stages: Series C+ 13, Series B 10, Series A 7, Undisclosed 3, Seed 2, Growth 1
Stuut $52.5M Series BHestus, Inc. $7.4M SeedQuartermaster $140M Series B equity + debt facilityNew companies 30 · Follow-on 5
Stages: Series B 10, Series C+ 9, Series A 8, Seed 3, Undisclosed 3, Pre-seed 2
Nous Research $90M Series BArmadin $255.5M Series BFactory $200M FundingNew companies 33 · Follow-on 2
Stages: Seed 12, Series A 8, Series C+ 8, Series B 5, Pre-seed 1, Undisclosed 1
General Medicine $120M Series BSafeWorld $12.2M SeedCorridor $25M SeedNew companies 31 · Follow-on 1
Stages: Series C+ 14, Series B 7, Seed 4, Series A 4, Undisclosed 2, Growth 1
Savvy Wealth $100M Series CAugmeta $3M SeedAndo $20M Combined pre-seed and seedNew companies 29 · Follow-on 2
Stages: Series C+ 11, Series A 7, Series B 7, Undisclosed 3, Seed 2, Growth 1
Multiply Labs $75M Series BVarda $251M Series DCrusoe $3.9B Series F (initial close; anticipated total)New companies 31 · Follow-on 0
Stages: Seed 14, Undisclosed 6, Series A 5, Pre-seed 3, Series C+ 2, Series B 1
Tab Undisclosed UndisclosedSafeWorld $12.2M SeedGhost $11M SeedNew companies 29 · Follow-on 1
Stages: Series C+ 10, Series B 8, Series A 5, Seed 3, Undisclosed 3, Growth 1
Armadin $255.5M Series BSnorkel AI $350M Series EEncoded Therapeutics Inc. $275M Series FNew companies 27 · Follow-on 2
Stages: Series C+ 8, Series B 7, Seed 5, Series A 5, Growth 2, Undisclosed 2
Multiply Labs $75M Series BVarda $251M Series DEnveda $311M Series ENew companies 28 · Follow-on 1
Stages: Series C+ 11, Series A 7, Series B 7, Seed 4
Armadin $255.5M Series BSolcoa Industries $75M Seed financing; equity, debt, and equipment financingAnde Undisclosed Series ANew companies 26 · Follow-on 3
Stages: Series C+ 11, Series A 7, Series B 4, Seed 3, Growth 2, Undisclosed 2
Armadin $255.5M Series BProfound $180M Series DHarvey $550M Series HNew companies 28 · Follow-on 1
Stages: Series A 10, Series C+ 10, Series B 5, Undisclosed 2, Pre-seed 1, Seed 1
HiringCafe $6.8M Pre-seedRune $40M Series APiston $15M Series ANew companies 24 · Follow-on 1
Stages: Series A 8, Series B 6, Seed 4, Series C+ 4, Undisclosed 3
Healthleap $8M SeedQuartermaster $140M Series B equity + debt facilityAranya $9M SeedNew companies 23 · Follow-on 1
Stages: Series B 8, Series C+ 7, Growth 4, Series A 3, Seed 1, Undisclosed 1
Miter $40M Series BFeldera $15.4M Series APhigenics Undisclosed InvestmentNew companies 22 · Follow-on 2
Stages: Series C+ 14, Growth 3, Series B 3, Series A 2, Undisclosed 2
Miter $40M Series BInstinct $1B Series CLightfield $47M Series ANew companies 22 · Follow-on 1
Stages: Series A 7, Series B 6, Series C+ 6, Seed 2, Undisclosed 2
Arena $200M Series BNumeral $100M Series CCrusoe $3.9B Series F (initial close; anticipated total)New companies 23 · Follow-on 0
Stages: Series C+ 7, Series B 6, Series A 5, Undisclosed 4, Seed 1
Mecka $60M Series BNous Research $90M Series BGMI Cloud $223M Series BNew companies 20 · Follow-on 2
Stages: Series A 7, Series B 6, Seed 4, Series C+ 4, Undisclosed 1
Arena $200M Series BSolcoa Industries $75M Seed financing; equity, debt, and equipment financingSmack Technologies $61M Series BNew companies 20 · Follow-on 2
Stages: Series C+ 10, Series B 4, Series A 3, Seed 2, Undisclosed 2, Pre-seed 1
Vinci $250M Series BEfficient Computer $100M Additional fundingPrime Minute $15M Pre-SeedNew companies 20 · Follow-on 2
Stages: Series C+ 14, Series A 3, Series B 3, Seed 1, Undisclosed 1
Savvy Wealth $100M Series CRightway $155M Series ESavvy Wealth $100M Series CNew companies 21 · Follow-on 1
Stages: Series C+ 11, Series B 5, Undisclosed 4, Growth 1, Series A 1
CScale $145M Series CGeneral Intuition $220M UndisclosedCrusoe $3.9B Series F (initial close; anticipated total)“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.